drugset / Trial / NCT00100971
Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia
Treatment
Summary
RATIONALE: Vaccines made from a person's white blood cells and cancer cells may make the body build an effective immune response to kill cancer cells. PURPOSE: This phase I trial is studying the side effects and best dose of vaccine therapy in treating patients with acute myeloid leukemia.
Timeline
- Start
- 2004-04
- Primary completion
- 2007-03
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous tumor cell vaccine | Vaccine | — | Subcutaneous |
| Subject | therapeutic autologous dendritic cells | Vaccine | — | Subcutaneous |